May 08, 2013 (The Australian Financial Review - ABIX via COMTEX) --
Sigma Pharmaceuticals CEO Mark Hooper says the group is trying to reduce its dependence on the Pharmaceutical Benefits Scheme for its revenue. Hooper was speaking at the drug distributor's AGM on 8 May 2013. He also said that Sigma has achieved a record return on invested capital in 2012-13, while chairman Brian Jamieson said Sigma should be able to sustain its high dividend payout levels for the next few years.
Publication Date: 9 May 2013
SIGMA PHARMACEUTICALS LIMITED - ASX SIP
AUSTRALIAN SHAREHOLDERS' ASSOCIATION
AUSTRALIA. PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE